Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from efavirenz to Kaletra to assess cognitive function in treated HIV patients
ISRCTN73411795Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Jan 2013
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of lopinavir + ritonavir and efavirenz in human immunodeficiency virus infection (HIV), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Change in cognitive test scores. Started Jan 2013; status: completed.
02
Drugs
lopinavir + ritonavirefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ISRCTN73411795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN73411795.